680 related articles for article (PubMed ID: 19607771)
1. What to do when warfarin therapy goes too far.
Prasad S; Wootten MR; Kulinski N; Chapman SA
J Fam Pract; 2009 Jul; 58(7):346-52. PubMed ID: 19607771
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy and safety profiles of intravenous vitamin K and fresh frozen plasma as treatment of warfarin-related over-anticoagulation in patients with mechanical heart valves.
Yiu KH; Siu CW; Jim MH; Tse HF; Fan K; Chau MC; Chow WH
Am J Cardiol; 2006 Feb; 97(3):409-11. PubMed ID: 16442406
[TBL] [Abstract][Full Text] [Related]
3. The risk of hemorrhage among patients with warfarin-associated coagulopathy.
Garcia DA; Regan S; Crowther M; Hylek EM
J Am Coll Cardiol; 2006 Feb; 47(4):804-8. PubMed ID: 16487849
[TBL] [Abstract][Full Text] [Related]
4. Retrospective evaluation of a method to predict fresh-frozen plasma dosage in anticoagulated patients.
Frazee LA; Bourguet CC; Gutierrez W; Elder-Arrington J; Elackattu AE; Haller NA
Am J Ther; 2008; 15(2):111-8. PubMed ID: 18356630
[TBL] [Abstract][Full Text] [Related]
5. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
Yasaka M; Sakata T; Naritomi H; Minematsu K
Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
[TBL] [Abstract][Full Text] [Related]
6. Vitamin K dosing to reverse warfarin based on INR, route of administration, and home warfarin dose in the acute/critical care setting.
Tsu LV; Dienes JE; Dager WE
Ann Pharmacother; 2012 Dec; 46(12):1617-26. PubMed ID: 23249867
[TBL] [Abstract][Full Text] [Related]
7. Bleeding risks and response to therapy in patients with INR higher than 9.
Pagano MB; Chandler WL
Am J Clin Pathol; 2012 Oct; 138(4):546-50. PubMed ID: 23010709
[TBL] [Abstract][Full Text] [Related]
8. Elevated international normalized ratio from vitamin K supplement discontinuation.
Miesner AR; Sullivan TS
Ann Pharmacother; 2011 Jan; 45(1):e2. PubMed ID: 21205949
[TBL] [Abstract][Full Text] [Related]
9. Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy.
Sarode R; Rawal A; Lee R; Shen YM; Frenkel EP
Br J Haematol; 2006 Mar; 132(5):604-7. PubMed ID: 16445834
[TBL] [Abstract][Full Text] [Related]
10. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy.
Makris M; Greaves M; Phillips WS; Kitchen S; Rosendaal FR; Preston EF
Thromb Haemost; 1997 Mar; 77(3):477-80. PubMed ID: 9065997
[TBL] [Abstract][Full Text] [Related]
11. Hemorrhagic events lead to an increase in international normalized ratio in patients on warfarin.
Perona S; Ford M; Rindone J
J Pharm Pract; 2011 Oct; 24(5):494-7. PubMed ID: 22156711
[TBL] [Abstract][Full Text] [Related]
12. Effect of therapeutic INR on activated clotting times, heparin dosage, and bleeding risk during ablation of atrial fibrillation.
Gautam S; John RM; Stevenson WG; Jain R; Epstein LM; Tedrow U; Koplan BA; McClennen S; Michaud GF
J Cardiovasc Electrophysiol; 2011 Mar; 22(3):248-54. PubMed ID: 20812929
[TBL] [Abstract][Full Text] [Related]
13. [Hemorrhagic complications during warfarin treatment].
Gumulec J; Kessler P; Penka M; Klodová D; Králová S; Brejcha M; Wróbel M; Sumná E; Blatný J; Klaricová K; Riedlová P; Lasota Z
Vnitr Lek; 2006 Mar; 52 Suppl 1():79-91. PubMed ID: 16637455
[TBL] [Abstract][Full Text] [Related]
14. Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10. Results of a prospective cohort study.
Crowther MA; Garcia D; Ageno W; Wang L; Witt DM; Clark NP; Blostein MD; Kahn SR; Schulman S; Kovacs M; Rodger MA; Wells P; Anderson D; Ginsberg J; Selby R; Siragusa S; Silingardi M; Dowd MB; Kearon C
Thromb Haemost; 2010 Jul; 104(1):118-21. PubMed ID: 20458438
[TBL] [Abstract][Full Text] [Related]
15. Warfarin therapy: evolving strategies in anticoagulation.
Horton JD; Bushwick BM
Am Fam Physician; 1999 Feb; 59(3):635-46. PubMed ID: 10029789
[TBL] [Abstract][Full Text] [Related]
16. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Ansell J; Hirsh J; Poller L; Bussey H; Jacobson A; Hylek E
Chest; 2004 Sep; 126(3 Suppl):204S-233S. PubMed ID: 15383473
[TBL] [Abstract][Full Text] [Related]
17. Warfarin prevalence, indications for use and haemorrhagic events.
Ouirke W; Cahill M; Perera K; Sargent J; Conway J
Ir Med J; 2007 Mar; 100(3):402-4. PubMed ID: 17491542
[TBL] [Abstract][Full Text] [Related]
18. [The application of thrombin generation tests to warfarin anticoagulation monitoring].
Chen HY; Ding QL; Zhang LW; Xu GQ; Dai J; Wang XF; Xi XD; Wang HL
Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):168-70. PubMed ID: 18788615
[TBL] [Abstract][Full Text] [Related]
19. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
Poon IO; Lal L; Brown EN; Braun UK
J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
[TBL] [Abstract][Full Text] [Related]
20. Failure to correct International Normalized Ratio and mortality among patients with warfarin-related major bleeding: an analysis of electronic health records.
Menzin J; Hoesche J; Friedman M; Nichols C; Bergman GE; Crowther M; Garcia D; Jones C
J Thromb Haemost; 2012 Apr; 10(4):596-605. PubMed ID: 22257107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
